| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
| Targets |
IC50: 5 nM (CTX-M-15), 8 nM (TEM-1)[1]
|
|---|---|
| ln Vitro |
Avibactam is a compound with minimal antibacterial action that inhibits Acinetobacter OXA carbapenemases and class A and C β-lactamases, but not metallo types[2]. With MIC50 and MIC90 for both 8 mg/L, ceftazidime (HY-B0593)-avibactam (0-256 mg/L) suppresses the growth of 16 blaKPC -2 positive and 1 blaOXA-232 positive Klebsiella pneumonia[4].
|
| ln Vivo |
Ceftazidime-Avibactam (0.375 mg/g; sc; q8h for 10 days) significantly affects the bacteria and has been shown to have some therapeutic activity in an infected animal model with K. pneumoniae strain Y8[3]. In neutropenic mice infected with Pseudomonas aeruginosa and suffering from lung infection, avibactam (64 mg/kg; sc; once) has a mean estimated half-life in plasma in the terminal phase of 0.24 h[3].
|
| Animal Protocol |
Animal/Disease Models: Sixweeks old balb/c (Bagg ALBino) mouse: (female), K. pneumoniae strain Y8 infection model[4]
Doses: 0.375 mg/g in combination with Ceftazidime Route of Administration: subcutaneous (sc)injection, 4 h post infection and given every 8 h for 10 days Experimental Results: 70% of infection group mice died within 4 days, and all mice in the PBS group died within 13 days. All treatment group mice survived at 10 days post infection with the antibiotic applied every 8 h, whereas 100% of mice in this group died within 4 days after the antibiotic treatment stopped. The spleen and liver of treatment group mice demonstrated lower CFU counts, as compared with that of infected group. |
| References |
[1]. Ehmann DE, et al. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor. Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11663-8.
[2]. Livermore DM, et al. Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104). J Antimicrob Chemother. 2012 Jun;67(6):1354-8. [3]. Berkhout J, et al. Pharmacokinetics and penetration of GR20263 and avibactam into epithelial lining fluid in thigh- and lung-infected mice. Antimicrob Agents Chemother. 2015 Apr;59(4):2299-304. [4]. Zhang W, et al. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae. Antimicrob Resist Infect Control. 2018 Nov 21;7:142. |
| Molecular Formula |
C7H12N3NAO7S
|
|---|---|
| Molecular Weight |
305.24
|
| CAS # |
2938989-90-1
|
| Related CAS # |
Avibactam free acid;1192500-31-4;Avibactam sodium;1192491-61-4;Avibactam sodium dihydrate
|
| Appearance |
Typically exists as solids (or liquids in special cases) at room temperature
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ≥ 200 mg/mL (655.22 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 25 mg/mL (81.90 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.2761 mL | 16.3806 mL | 32.7611 mL | |
| 5 mM | 0.6552 mL | 3.2761 mL | 6.5522 mL | |
| 10 mM | 0.3276 mL | 1.6381 mL | 3.2761 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
